ABCL: AbCellera Biologics Inc. Growth-Adjusted Market Cap to Net Income
The PEG ratio demonstrates a struggle between buyers and sellers, with 0.00 representing a fresh level. AbCellera Biologics (ABCL) price action remains independent of macroeconomics, as profits are based on royalties and research milestones. AbCellera Biologics (ABCL) utilizes AI for accelerated antibody discovery within the B2B sector. Stability is ensured by the international diversification of biocomponent supplies for laboratories.
Metric breakdowns and analytics for AbCellera (ABCL)
- share price and consensus valuation forecast:
- market capitalization information:
- company book value details:
- issuer credit burden and liquidity indicators:
- business earnings and investment ratios data:
ABCL - Net Profit|Future Profit AbCellera Biologics|ABCL - P/E Multiple|Projected Price to Earnings Ratio AbCellera Bio|ABCL - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AbCellera Corp|ABCL - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months AbCellera|ABCL - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months abcellera.com|ABCL - Earnings per share growth in current year|Expected earnings per share trend next year AbCellera Biologics
General company analysis:ABCL - AbCellera Corp
Reductions in partner R&D budgets are putting pressure on AbCellera Biologics (ABCL) revenue, although a significant liquidity reserve stabilizes operational resilience. The peg_co multiple compares the current P/E to earnings growth rates to identify asset undervaluation; a drop in this indicator below one signals high investment attractiveness for the company relative to its expansion dynamics and market capitalization.
Competing companies
ARGX (argenx N.V.) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (BioNTech Group)|Growth-Adjusted Market Cap to Net Income Abivax (ABVX)|ADMA - Price/Earnings to Growth Ratio|protagonist-inc.com (PTGX) - Price/Earnings to Growth Multiple|Immunovant (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals, Ltd.|Price/Earnings to Growth Multiple GRFS|PEG Multiple Adaptive Biotechnologies Inc.|Price/Earnings to Growth Ratio Celldex Therapeutics (CLDX)|auriniapharma.com - Growth-Adjusted P/E Ratio|PEG Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Price to Earnings Adjusted for Growth Rate|Dianthus Pharma - PEG Multiple|PHVS - PEG Multiple|TRML: PEG Multiple|PGEN (precigen.com) - Price/Earnings to Growth Ratio|PHAR (Pharming Group) - PEG Multiple|Price/Earnings to Growth Multiple Nektar Therapeutics Inc (NKTR)|PEG Multiple UPB|ZBIO - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Immunome, Inc. IMNM|gossamerbio.com - Price/Earnings to Growth Ratio|KALV - Price/Earnings to Growth Ratio|SEPN: Price/Earnings to Growth Ratio|PVLA: PEG Multiple|Price to Earnings Adjusted for Growth Rate Savara Pharma (SVRA)|Price/Earnings to Growth Ratio Rigel Pharmaceuticals|ANAB: Growth-Adjusted Payback Ratio|PEG Multiple ATXS|PEG Multiple enGene Holdings Inc (ENGN)|RAPT Therapeutics, Inc. - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio JBIO|Aclaris Therapeutics - PEG Multiple|KYTX: Price/Earnings to Growth Ratio|TLSA: PEG Multiple|CABA - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Ventyx Bio|Price to Earnings Adjusted for Growth Rate Theratechnologies, Inc THTX|Price/Earnings to Growth Ratio Avalo Therapeutics, Inc (AVTX)|Price/Earnings to Growth Ratio ELDN (eledon.com)|Price/Earnings to Growth Ratio Agenus Inc. AGEN|Climb Bio Inc. (CLYM) - Price to Earnings Adjusted for Growth Rate|Zura Bio Limited - PEG Multiple|Price to Net Income Growth Ratio aTyr Pharmaceuticals (ATYR)|ADAG: PEG Multiple|IMA - Growth-Adjusted Market Cap to Net Income|STTK (Shattuck Labs Inc) - PEG Multiple|Price/Earnings to Growth Multiple Equillium Bio (EQ)|Price/Earnings to Growth Ratio Connect Biopharma (CNTB)|Growth-Adjusted Market Cap to Net Income immunic-therapeutics.com|PEG Multiple ATRA (Atara Bio)|PEG Multiple InflaRx NV IFRX|X4 Pharmaceuticals, Inc. - PEG Multiple|ACET: Price/Earnings to Growth Ratio|CELU: PEG Multiple|Price/Earnings to Growth Multiple INmune Bio Corporation|Price/Earnings to Growth Ratio Barinthus Biotherapeutics|Price/Earnings to Growth Ratio KZR|Price/Earnings to Growth Ratio SAB Biotherapeutics, Inc. (SABS)|AKTX: Market Cap to Earnings and Growth Ratio|PEG Multiple ENLV (Enlivex Therapeutics Ltd.)|Growth-Adjusted Payback Ratio QTTB|GeoVax Labs, Inc. - PEG Multiple|EDSA - PEG Multiple|iBio (IBIO) - Price/Earnings to Growth Ratio|Carisma Therapeutics Inc. - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio XTL Biopharmaceuticals, Ltd.|Price/Earnings to Growth Multiple Bolt Bio (BOLT)|PEG Multiple HCWB|PEG Multiple aptevotherapeutics.com (APVO)|AIM ImmunoTech - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio ADTX|GRI Bio Corp - PEG Multiple|Growth-Adjusted Market Cap to Net Income XORTX Corp XRTX|Vyome Holdings Inc (HIND) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple revbiosciences.com|Price/Earnings to Growth Ratio Indaptus Therapeutics, Inc.|Price/Earnings to Growth Multiple Scinai Immunotherapeutics Ltd (SCNI)|Price/Earnings to Growth Multiple CALI (CalciMedica, Inc.)|PEG Multiple affimed.com (AFMD)|Price/Earnings to Growth Ratio Allakos ALLK|HOOK: Growth-Adjusted P/E Ratio|IGM Bio - PEG Multiple|Price to Earnings Adjusted for Growth Rate iTeos Therapeutics Inc|OCEA: PEG Multiple|TC BioPharm Ltd (TCBP) - PEG Multiple|THRD (Third Harmonic Bio) - PEG Multiple
